Inventor · disambiguated record
Anat Globerson Levin
Also filed as: GLOBERSON LEVIN ANAT
3 granted patents·6 pending applications·0 citations·filing 2018–2024
42Inventor score
Files withMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT3YEDA RES & DEV3UNIV RAMOT2ICHILOV TECH LTD1
Top patents by PatentIndex Score
9 records- 0168US2024139247A1T-cells comprising anti-cd38 and anti-cd138 chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2024·Application pending·0 cites
- 0261US11944644B2T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2018·Granted Apr 2, 2024·0 cites·19 claims
- 0354US2023321235A1Veto car-t cellsYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 0452US2023167158A1Pseudotyped viruses configured to express car in t-cellsICHILOV TECH LTD·Filed 2023·Application pending·0 cites
- 0550US2024216510A1Chimeric antigen receptors to sialyl-tn glycan antigenUNIV RAMOT·Filed 2022·Application pending·0 cites
- 0647US2022204928A1Extracellular vesicles derived from activated car-t cellsYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 0745US11932871B2Methods of culturing t cells and uses of sameYEDA RES & DEV·Filed 2018·Granted Mar 19, 2024·0 cites·10 claims
- 0844US2023058044A1Chimeric antigen receptor to carbohydrate antigensUNIV RAMOT·Filed 2020·Application pending·0 cites
- 0937US12139522B2T-cells comprising two different chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2018·Granted Nov 12, 2024·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Anat Globerson Levin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →